Effectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the Elderly
Condition(s):COVID-19; Vaccine Adverse Reaction; Vaccine-Preventable DiseasesLast Updated:March 17, 2022Unknown status
Hide Studies Not Open or Pending
Condition(s):COVID-19; Vaccine Adverse Reaction; Vaccine-Preventable DiseasesLast Updated:March 17, 2022Unknown status
Condition(s):COVID-19Last Updated:March 27, 2023Recruiting
Condition(s):COVID-19 Pneumonia; COVID-19Last Updated:October 19, 2023Completed
Condition(s):COVID-19; Vaccine Adverse Reaction; Vaccine Reaction; Vaccine or Biological Substance, Unspecified Causing Adverse Effects in Therapeutic Use; Corona Virus Infection; Blood Clot; Thrombocytopenia; Neuritis; Vasculitis; Influenza; Guillain-Barré; GWAS; Genetic SequencingLast Updated:March 18, 2022Recruiting
Condition(s):Anaphylactic Reaction; Vaccine ReactionLast Updated:October 20, 2021Unknown status
Condition(s):Healthy VolunteersLast Updated:April 27, 2023Active, not recruiting
Condition(s):Rheumatoid Arthritis (RA); Systemic Lupus Erythematosus (SLE); Pemphigus Vulgaris; Multiple Sclerosis (MS); Systemic Sclerosis (SSc); Pediatric SLE; Juvenile Idiopathic Arthritis (JIA); Juvenile Dermatomyositis (JDM); Pediatric-Onset Multiple Sclerosis (POMS)Last Updated:March 26, 2024Active, not recruiting
Condition(s):Adverse Reaction to Vaccine; COVID19 VaccineLast Updated:April 6, 2022Recruiting
Condition(s):Covid-19 Pandemics; TuberculosisLast Updated:June 23, 2023Enrolling by invitation
Condition(s):SARS CoV 2 InfectionLast Updated:August 1, 2022Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.